Related Experiment Video
Updated: Jul 14, 2026
07:52
Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
Published on: July 23, 2012
CD34 facilitates the development of allergic asthma
Marie-Renée Blanchet1, Steven Maltby, D James Haddon
1The Biomedical Research Centre, University of British Columbia, Vancouver, Canada.
Blood
|June 15, 2007
Summary
CD34 expression on immune cells is crucial for developing allergic asthma. Mice lacking CD34 showed significantly reduced asthma symptoms, indicating CD34
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- Asthma is a chronic inflammatory lung disease characterized by eosinophil and mast cell infiltration.
- CD34, a sialomucin, is expressed on eosinophils and mast cells, key players in asthma pathogenesis.
Purpose of the Study:
- To investigate the role of CD34 expression in the development of allergic asthma.
- To determine if CD34 on bone marrow-derived cells is essential for asthma hallmarks.
Main Methods:
- Utilized a standard mouse model of allergic asthma.
- Employed CD34-deficient (CD34(-/-)) and wild-type (wt) mice.
- Conducted bone marrow transplantation experiments to trace CD34 function to bone marrow-derived cells.
- Assessed airway inflammation, hyperresponsiveness, and cellular infiltration.
- Performed in vitro migration assays on eosinophils.
Main Results:
- CD34(-/-) mice displayed significantly reduced airway inflammation, hyperresponsiveness, and mast cell recruitment compared to wt mice.
- Bone marrow transplantation confirmed that CD34 expression on bone marrow-derived cells is critical for asthma development.
- CD34 deficiency did not impair antigen-specific cytokine production by inflammatory cells.
- CD34(-/-) eosinophils showed markedly reduced in vitro mobility, suggesting impaired invasiveness.
Conclusions:
- CD34 expression by mast cells and eosinophils is essential for the development of allergic asthma.
- CD34 appears to enhance the invasiveness of these inflammatory cells, facilitating their recruitment to the lungs.
- Targeting CD34 may offer a therapeutic strategy for managing allergic asthma.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
02:06Allergic Reactions
Overview
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...